irasia.com - Investor Relations Asia Pacific
HOME

Living Cell Technologies Limited

Press Releases


Please download the latest "Acrobat Reader" to view the PDF.

  • 2010-December-31
  • LCT Executes AUD 5,750,000 Funding Agreement (in PDF)
  • 2010-December-23
  • LCT Negotiating Funding (in PDF)
  • 2010-December-20
  • LCT Approved to Further Expand DIABECELL® NZ Trial (in PDF)
  • 2010-December-10
  • LCT's DIABECELL® Registered for Sale and Use in Russia (in PDF)
  • 2010-November-18
  • LCT Appoints New Chairman (in PDF)
  • 2010-November-10
  • Promising Preclinical Results with NTCELL in Parkinson's (in PDF)
  • 2010-October-29
  • Appendix 4C Quarterly Cash Flow Report to 30 September 2010 (in PDF)
  • 2010-October-27
  • LCT Reports Sustained Improvement from DIABECELL NZ Trial (in PDF)
  • 2010-October-1
  • LCT Managing Director to Speak at American Investor Forum (in PDF)
  • 2010-September-23
  • LCT Restructures Executive Team for Commercial Focus (in PDF)
  • 2010-August-27
  • Preliminary Final Report for the Year Ended 30 June 2010 (in PDF)
  • 2010-August-6
  • Managing Director's Remuneration (in PDF)
  • 2010-August-4
  • LCT Receives Approval to Expand DIABECELL® NZ Trial (in PDF)
  • 2010-August-2
  • LCT Enhances Management Team: Managing Director Appointed (in PDF)
  • 2010-July-30
  • Appendix 4C Quarterly Cash Flow Report to 30 June 2010 (in PDF)
  • 2010-July-13
  • LCT Reports Consistent Benefit in DIABECELL® NZ Trial (in PDF)
  • 2010-June-28
  • LCT Presentation at American Diabetes Association (in PDF)
  • 2010-June-22
  • LCT Options Expiring 30th June 2010 to be Underwritten (in PDF)
  • 2010-June-10
  • LCT Works with NZ Government on Animal Derived Biologics (in PDF)
  • 2010-April-29
  • Appendix 4C Quarterly Cash Flow Report to 31 March 2010 (in PDF)
  • 2010-April-27
  • LCT Receives Grant from JDRF, Living Cell Technologies Receives Grant from Juvenile Diabetes Research Foundation International for DIABECELL® NZ Clinical Trial (in PDF)
  • 2010-April-13
  • Living Cell Technologies' Paper Selected for "Best Publications of 2009" by Journal of Neural Engineering (in PDF)
  • 2010-April-7
  • Report from LCT's Russian Phase I/IIa Diabetes Trial, Living Cell Technologies Confirms Safety and Proof of Principle of Efficacy in its Penultimate Data Analysis from its Russian Human Phase I/IIa Trial with DIABECELL® in Diabetics (in PDF)
  • 2010-March-30
  • LCT Phase II Diabetes Trial Success: Approval to Progress (in PDF)
  • 2010-March-10
  • Living Cell Technologies' Encapsulation Device Granted Registration in Russia (in PDF)
  • 2010-February-25
  • Living Cell Technologies Half Yearly Report Period Ended 31 December 2009 (in PDF)
  • 2010-February-12
  • Living Cell Technologies Awarded NZ$4.04 Million New Zealand Government Grant to advance DIABECELL® for type 1 diabetes (in PDF)
  • 2010-February-9
  • Living Cell Technologies Receives 10% of US Based Wound Healing Company in Supply and Licence Agreement (in PDF)
  • 2010-January-29
  • Appendix 4C Quarterly Cash Flow Report to 31 December 2009 (in PDF)
  • 2010-January-27
  • Living Cell Technologies Alerted to Issue of Fake Share Certificates (in PDF)
  • 2010-January-20
  • Living Cell Technologies Granted European Patent for Neurological Disease Product NTCELL (in PDF)
  • 2019
  • 2019 Press Releases
  • 2018
  • 2018 Press Releases
  • 2017
  • 2017 Press Releases
  • 2016
  • 2016 Press Releases
  • 2015
  • 2015 Press Releases
  • 2014
  • 2014 Press Releases
  • 2013
  • 2013 Press Releases
  • 2012
  • 2012 Press Releases
  • 2011
  • 2011 Press Releases
  • 2009
  • 2009 Press Releases
  • 2008
  • 2008 Press Releases
  • 2007
  • 2007 Press Releases


  • Company's Index
  • irasia.com

  • About irasia.com   |   Terms of Use   |   Disclaimer
    © Copyright 1996-2019 irasia.com Ltd. All rights reserved.
    DISCLAIMER:
    irasia.com Ltd. makes no guarantee as to the accuracy or completeness of any information provided on this website. Under no circumstances shall irasia.com Ltd. be liable for damages resulting from the use of the information provided on this website.